Delayed Addition of Deoxycytidine Protects Normal CD34 + Cells against Cytotoxicity of Gemcitabine without Compromising Its Activity against Human Leukemic Cells-Reference-Cited by-同舟云学术

Delayed Addition of Deoxycytidine Protects Normal CD34 + Cells against Cytotoxicity of Gemcitabine without Compromising Its Activity against Human Leukemic Cells

Published:2003-05 Issue:3 Volume:21 Page:266-271
ISSN:1066-5099
Container-title:STEM CELLS
language:en
Short-container-title:STEM CELLS

Author:

Tiefenthaler Martin¹,Hohla Florian²,Strasser‐Wozak Elisabeth²,Bacher Nicole²,Mühlmann Oliver²,Wein Wolfgang³,Konwalinka Günther²

Affiliation:

1. Department of Nephrology, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

2. Department of Internal Medicine, Faculty of Medicine, University of Innsbruck, Innsbruck, Austria

3. Eli Lilly Area Medical Center, Vienna, Austria

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/stemcells.21-3-266

Reference20 articles.

1. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′ difluorodeoxycytidine and 1‐B‐D‐arabinofuranosylcytosine;Heinemann V;Cancer Res,1988

2. 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia Cells

3. Inhibition of ribonucleotide reduction in CCRF‐CEM cells by 2′,2 difluorodeoxycytidine;Heinemann V;Mol Pharmacol,1990

4. Evaluation of the antitumor activity of gemcitabine (2′,2′‐difluoro‐2′‐deoxycytidine);Hertel LW;Cancer Res,1990

5. Preclinical in vivo activity of 2′,2′ difluorodeoxycytidine (gemcitabine) against head and neck cancer;Braakhuis BJ;Cancer Res,1991

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular imaging of deoxycytidine kinase activity using deoxycytidine-enhanced CEST MRI;Cancer Research;2019-04-02